BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 20649758)

  • 1. Prognostic study of cardiac and renal events in Japanese patients with chronic kidney disease and cardiovascular risk using myocardial perfusion SPECT: J-ACCESS 3 study design.
    Nakamura S; Kawano Y; Hase H; Hatta T; Nishimura S; Moroi M; Nakagawa S; Kasai T; Kusuoka H; Takeishi Y; Nakajima K; Momose M; Takehana K; Nanasato M; Yoda S; Nishina H; Matsumoto N; Nishimura T
    Ther Apher Dial; 2010 Aug; 14(4):379-85. PubMed ID: 20649758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of myocardial perfusion SPECT images in combination with the maximal heart rate at exercise testing in Japanese patients with suspected ischemic heart disease: a sub-analysis of J-ACCESS.
    Ueshima K; Yamashina A; Usami S; Yasuno S; Nishiyama O; Yamazaki T; Nakao K; Nishimura T
    Ann Nucl Med; 2009 Dec; 23(10):849-54. PubMed ID: 19898922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relation between prognosis and myocardial perfusion imaging from the difference of end-point criterion for exercise stress testing: a sub-analysis of the J-ACCESS study.
    Muramatsu T; Nishimura S; Yamashina A; Nishimura T;
    J Cardiol; 2010 Jul; 56(1):51-8. PubMed ID: 20381317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk stratification of cardiovascular events in patients at all stages of chronic kidney disease using myocardial perfusion SPECT.
    Yoda S; Nakanishi K; Tano A; Kasamaki Y; Kunimoto S; Matsumoto N; Sato Y; Hirayama A
    J Cardiol; 2012 Nov; 60(5):377-82. PubMed ID: 22890072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rationale and design of J-ACCESS 4: prognostic impact of reducing myocardial ischemia identified using ECG-gated myocardial perfusion SPECT in Japanese patients with coronary artery disease.
    Nanasato M; Nakajima K; Fujita H; Zen K; Kohsaka S; Hashimoto A; Moroi M; Fukuzawa S; Chikamori T; Nishimura S; Yamashina A; Kusuoka H; Hirayama A; Nishimura T
    J Cardiol; 2014 Feb; 63(2):159-64. PubMed ID: 24012330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive value of myocardial perfusion single-photon emission computed tomography and the impact of renal function on cardiac death.
    Hakeem A; Bhatti S; Dillie KS; Cook JR; Samad Z; Roth-Cline MD; Chang SM
    Circulation; 2008 Dec; 118(24):2540-9. PubMed ID: 19047585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surveillance study for creating the national clinical database relating to ECG-gated myocardial perfusion SPECT of asymptomatic ischemic heart disease in patients with type-2 diabetes mellitus: J-ACCESS 2 study design.
    Kusuoka H; Yamasaki Y; Izumi T; Kashiwagi A; Kawamori R; Shimamoto K; Yamada N; Nishimura T
    Ann Nucl Med; 2008 Jan; 22(1):13-21. PubMed ID: 18250983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of new-onset refractory congestive heart failure using gated myocardial perfusion SPECT imaging in patients with known or suspected coronary artery disease subanalysis of the J-ACCESS database.
    Nakata T; Hashimoto A; Wakabayashi T; Kusuoka H; Nishimura T
    JACC Cardiovasc Imaging; 2009 Dec; 2(12):1393-400. PubMed ID: 20083074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenosine-induced ST segment depression with normal perfusion.
    Hage FG; Heo J; Iskandrian AE
    Cardiol J; 2009; 16(2):121-6. PubMed ID: 19387958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of cardiac magnetic resonance stress tests: adenosine stress perfusion and dobutamine stress wall motion imaging.
    Jahnke C; Nagel E; Gebker R; Kokocinski T; Kelle S; Manka R; Fleck E; Paetsch I
    Circulation; 2007 Apr; 115(13):1769-76. PubMed ID: 17353441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic kidney disease and mortality and morbidity among patients with established cardiovascular disease: a West of Ireland community-based cohort study.
    Glynn LG; Reddan D; Newell J; Hinde J; Buckley B; Murphy AW
    Nephrol Dial Transplant; 2007 Sep; 22(9):2586-94. PubMed ID: 17452408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myocardial microvascular disease and major adverse cardiovascular events in patients with end-stage renal disease: rationale and design of the MICROCARD study.
    Bejan-Angoulvant T; Bergerot C; Juillard L; Mezergues A; Morelon E; Pouteil-Noble C; André-Fouët X; Angoulvant D
    Nephrol Dial Transplant; 2012 Jul; 27(7):2886-91. PubMed ID: 22344775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac computed tomography and myocardial perfusion scintigraphy for risk stratification in asymptomatic individuals without known cardiovascular disease: a position statement of the Working Group on Nuclear Cardiology and Cardiac CT of the European Society of Cardiology.
    Perrone-Filardi P; Achenbach S; Möhlenkamp S; Reiner Z; Sambuceti G; Schuijf JD; Van der Wall E; Kaufmann PA; Knuuti J; Schroeder S; Zellweger MJ
    Eur Heart J; 2011 Aug; 32(16):1986-93, 1993a, 1993b. PubMed ID: 20630895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of myocardial scintigraphy in the assessment of cardiovascular risk in patients with end-stage chronic kidney disease on the waiting list for renal transplantation.
    Galvão De Lima JJ; Wolff Gowdak LH; de Paula FJ; Franchini Ramires JA; Bortolotto LA
    Nephrol Dial Transplant; 2012 Jul; 27(7):2979-84. PubMed ID: 22302207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic study of cardiac events in Japanese patients with chronic kidney disease using ECG-gated myocardial Perfusion imaging: Final 3-year report of the J-ACCESS 3 study.
    Nakamura S; Kawano Y; Nakajima K; Hase H; Joki N; Hatta T; Nishimura S; Moroi M; Nakagawa S; Kasai T; Kusuoka H; Takeishi Y; Momose M; Takehana K; Nanasato M; Yoda S; Nishina H; Matsumoto N; Nishimura T
    J Nucl Cardiol; 2019 Apr; 26(2):431-440. PubMed ID: 28439760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incremental prognostic value of myocardial perfusion imaging in patients referred to stress single-photon emission computed tomography with renal dysfunction.
    Al-Mallah MH; Hachamovitch R; Dorbala S; Di Carli MF
    Circ Cardiovasc Imaging; 2009 Nov; 2(6):429-36. PubMed ID: 19920040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for cardiovascular disease in patients with advanced chronic kidney disease.
    Sharma R
    J Ren Care; 2010 May; 36 Suppl 1():68-75. PubMed ID: 20586902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of myocardial perfusion and ventricular function in a Japanese multicenter cohort study (J-ACCESS): the first-year total events and hard events.
    Nakajima K; Kusuoka H; Nishimura S; Yamashina A; Nishimura T
    Ann Nucl Med; 2009 Jun; 23(4):373-81. PubMed ID: 19363705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of regadenoson myocardial single-photon emission computed tomography in patients with different degrees of renal dysfunction.
    Bhatti S; Hakeem A; Dhanalakota S; Palani G; Husain Z; Jacobsen G; Ananthasubramaniam K
    Eur Heart J Cardiovasc Imaging; 2014 Aug; 15(8):933-40. PubMed ID: 24699324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of myocardial perfusion single photon emission computed tomography for major adverse cardiac cerebrovascular and renal events in patients with chronic kidney disease: results from first year of follow-up of the Gunma-CKD SPECT multicenter study.
    Kasama S; Toyama T; Sato M; Sano H; Ueda T; Sasaki T; Nakahara T; Higuchi T; Tsushima Y; Kurabayashi M
    Eur J Nucl Med Mol Imaging; 2016 Feb; 43(2):302-311. PubMed ID: 26404015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.